AstraZeneca confirms delays to COVID-19 shots produced in Latin America
MEXICO CITY (Reuters) – AstraZeneca has confirmed setbacks to production of its COVID-19 vaccines in Latin America, excluding Brazil, but said it will still meet a commitment to deliver 150 million doses to the region this year.
The Anglo-Swedish drugmaker said in a statement shared with Reuters on Friday that lower-than-expected production, shortages of critical supplies and longer periods for regulatory approval had slowed the process.
Reporting by Adriana Barrera; Writing by Stefanie Eschenbacher; Editing by Frank Jack Daniel
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Bitcoin 
Ethereum 
Tether 
Solana 
BNB 
XRP 
Dogecoin 
USDC 
Cardano 
Lido Staked Ether